A comprehensive discussion is presented of the principles underlying the evaluation of safety data from controlled clinical trials. Emphasis is placed on clinical concepts rather than statistical methodology. The essential elements of safety analysis, the critical concepts involved, and trial design issues that affect the interpretation of safety data are explained. Particular attention is paid to the importance of exposure data, the estimation of adverse event frequencies in longer-term trials, evaluation of laboratory data, and the assessment of risk factors.
